Peptides for Hair Loss: KLOW and TB-500

Hair loss usually gets blamed on genetics and DHT. But for many people (especially women), chronic scalp inflammation and poor follicle blood supply are the real drivers. Peptides target exactly these mechanisms.

TB-500: follicle stem cell activation

[[TB-500|25]] (Thymosin Beta-4) activated hair follicle stem cells in Philp et al. (J Invest Dermatol, 2004). The protein stimulated new follicle formation in mice through effects on stem cell migration and differentiation.

TB-500 also reduces inflammatory cytokines (IL-1beta, IL-6, TNF-alpha), which is critical for follicles suffering from chronic inflammation.

KPV: targeted scalp anti-inflammation

KPV is a tripeptide fragment of alpha-MSH with potent NFkB pathway inhibition, central to inflammatory cascades. Chronic scalp inflammation causes follicle miniaturization: they shrink, produce thinner hair, eventually stop entirely. KPV interrupts this process at the signaling level.

KLOW: everything in one

[[KLOW|20]] combines BPC-157 + TB-500 + KPV + GHK-Cu (80mg). Four mechanisms at once:

• BPC-157: angiogenesis, improved scalp microcirculation
• TB-500: follicle stem cells + anti-inflammation
• KPV: targeted scalp inflammation suppression via NFkB
• GHK-Cu: tissue repair gene modulation and follicle support

For those who prefer a pen over a vial, [[KLOW Pen|39]] is available in the same formulation as a pre-filled pen.

What to expect

Hair follicles work in cycles (anagen-catagen-telogen), and any intervention needs at least 2-3 months for visible results. Reduced shedding is usually noticeable earlier (4-6 weeks), new growth later (8-12 weeks).

Questions about a hair protocol? Reach out to us.

This article is for educational purposes. Peptides are intended for research use. Consult a healthcare professional before starting any protocol.